Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage.
D000230:Adenocarcinoma / Q000276:immunology; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000961:Antilymphocyte Serum; D002277:Carcinoma / Q000276:immunology*; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D002648:Child; D005260:Female; D006258:Head and Neck Neoplasms / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D037102:Lectins; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008545:Melanoma / Q000276:immunology*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010386:Pelvic Neoplasms / Q000276:immunology; D012509:Sarcoma / Q000276:immunology*; D013936:Thymidine; D014316:Tritium
D000961:Antilymphocyte Serum; D037102:Lectins; D014316:Tritium; D013936:Thymidine